[
  {
    "ts": null,
    "headline": "Stocks to Watch Wednesday Recap: Netflix, QXO, Moderna, SLB",
    "summary": "↘️ Netflix (NFLX): An activist investor with a roughly $200 million stake in Warner Bros. Discovery (WBD) wants it to walk away from its Netflix deal. Ancora says Warner failed to adequately engage with Paramount Skydance (PSKY)’s rival offer.",
    "url": "https://finnhub.io/api/news?id=bdf51889d351d7294727bb2816098878a7cfef7f4e091d3f024a8058130edf95",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770852005,
      "headline": "Stocks to Watch Wednesday Recap: Netflix, QXO, Moderna, SLB",
      "id": 139051619,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "↘️ Netflix (NFLX): An activist investor with a roughly $200 million stake in Warner Bros. Discovery (WBD) wants it to walk away from its Netflix deal. Ancora says Warner failed to adequately engage with Paramount Skydance (PSKY)’s rival offer.",
      "url": "https://finnhub.io/api/news?id=bdf51889d351d7294727bb2816098878a7cfef7f4e091d3f024a8058130edf95"
    }
  },
  {
    "ts": null,
    "headline": "Earnings live: Cisco stock falls after outlook disappoints, McDonald's edges lower, Vertiv soars",
    "summary": "The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far.",
    "url": "https://finnhub.io/api/news?id=f7995dcd825ac7b2a3fab7b684dfe952b91afd451e7fad7537772738fa7a270c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770846350,
      "headline": "Earnings live: Cisco stock falls after outlook disappoints, McDonald's edges lower, Vertiv soars",
      "id": 139049491,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far.",
      "url": "https://finnhub.io/api/news?id=f7995dcd825ac7b2a3fab7b684dfe952b91afd451e7fad7537772738fa7a270c"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Stock Sinks on Flu Vaccine Rejection. Company Is ‘Desperately Seeking Clarification.’",
    "summary": "The vaccine maker says the Food and Drug Administration has refused to review its application to sell a new seasonal flu vaccine.",
    "url": "https://finnhub.io/api/news?id=43a38c4542392e7e2c1ad6313de2e6077f42ac602c54151305c5784d494a3dfd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770845760,
      "headline": "Moderna Stock Sinks on Flu Vaccine Rejection. Company Is ‘Desperately Seeking Clarification.’",
      "id": 139050682,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The vaccine maker says the Food and Drug Administration has refused to review its application to sell a new seasonal flu vaccine.",
      "url": "https://finnhub.io/api/news?id=43a38c4542392e7e2c1ad6313de2e6077f42ac602c54151305c5784d494a3dfd"
    }
  },
  {
    "ts": null,
    "headline": "Barclays Starts Moderna, Inc. (MRNA) Neutral as Biotech Outlook Improves",
    "summary": "We recently published an article titled 10 Best Long Term Healthcare Stocks to Buy. On January 28, Barclays assumed coverage of Moderna, Inc. (NASDAQ:MRNA) with an Equal Weight rating and a $25 price target as part of a broader biotechnology coverage expansion. The firm expressed a constructive view on the sector heading into 2026, citing […]",
    "url": "https://finnhub.io/api/news?id=6a08fbfa1d8a55b5cb5750495b73cc5aa07ee416fdc68dcb7935954edb626917",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770840830,
      "headline": "Barclays Starts Moderna, Inc. (MRNA) Neutral as Biotech Outlook Improves",
      "id": 139049685,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "We recently published an article titled 10 Best Long Term Healthcare Stocks to Buy. On January 28, Barclays assumed coverage of Moderna, Inc. (NASDAQ:MRNA) with an Equal Weight rating and a $25 price target as part of a broader biotechnology coverage expansion. The firm expressed a constructive view on the sector heading into 2026, citing […]",
      "url": "https://finnhub.io/api/news?id=6a08fbfa1d8a55b5cb5750495b73cc5aa07ee416fdc68dcb7935954edb626917"
    }
  },
  {
    "ts": null,
    "headline": "Mexico enlists Moderna to boost mRNA supply for respiratory diseases",
    "summary": "Unlike the US, Mexico is bolstering its mRNA offerings with the help of Moderna’s portfolio.",
    "url": "https://finnhub.io/api/news?id=2554ab213f8a2a5fdeb9c122e6c299415f251cc6ef91e15654b9c33156096d05",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770834816,
      "headline": "Mexico enlists Moderna to boost mRNA supply for respiratory diseases",
      "id": 139048275,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Unlike the US, Mexico is bolstering its mRNA offerings with the help of Moderna’s portfolio.",
      "url": "https://finnhub.io/api/news?id=2554ab213f8a2a5fdeb9c122e6c299415f251cc6ef91e15654b9c33156096d05"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Stock Sinks on Vaccine Rejection. Company Is ‘Desperately Seeking Clarification.’",
    "summary": "The vaccine maker says the Food and Drug Administration has refused to review its application to sell a new seasonal flu vaccine.",
    "url": "https://finnhub.io/api/news?id=1f8b3c2c279cf1781f776da0981025e949c6b42db614a49b402a3cf3324c2e27",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770833760,
      "headline": "Moderna Stock Sinks on Vaccine Rejection. Company Is ‘Desperately Seeking Clarification.’",
      "id": 139048276,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The vaccine maker says the Food and Drug Administration has refused to review its application to sell a new seasonal flu vaccine.",
      "url": "https://finnhub.io/api/news?id=1f8b3c2c279cf1781f776da0981025e949c6b42db614a49b402a3cf3324c2e27"
    }
  },
  {
    "ts": null,
    "headline": "FDA Letter Stalls Moderna Flu Filing While Stock Trades Above Targets",
    "summary": "FDA issues a Refusal to File letter to Moderna (NasdaqGS:MRNA) for its influenza vaccine candidate mRNA-1010. The decision centers on the choice of clinical trial comparator, not on safety or efficacy concerns. The FDA decline means the current application will not move into full review unless Moderna adjusts and resubmits. Moderna, known for its mRNA based Covid-19 vaccine, has been working to expand into seasonal respiratory vaccines, including flu. The FDA response on mRNA-1010 focuses...",
    "url": "https://finnhub.io/api/news?id=088a4d985503a7a3dea75887432995b1ef3338d38c075c548e4368bb96e189eb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770833506,
      "headline": "FDA Letter Stalls Moderna Flu Filing While Stock Trades Above Targets",
      "id": 139048277,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "FDA issues a Refusal to File letter to Moderna (NasdaqGS:MRNA) for its influenza vaccine candidate mRNA-1010. The decision centers on the choice of clinical trial comparator, not on safety or efficacy concerns. The FDA decline means the current application will not move into full review unless Moderna adjusts and resubmits. Moderna, known for its mRNA based Covid-19 vaccine, has been working to expand into seasonal respiratory vaccines, including flu. The FDA response on mRNA-1010 focuses...",
      "url": "https://finnhub.io/api/news?id=088a4d985503a7a3dea75887432995b1ef3338d38c075c548e4368bb96e189eb"
    }
  },
  {
    "ts": null,
    "headline": "Moderna's investigational flu vaccine denied FDA review, shares drop",
    "summary": "Moderna Inc (NASDAQ:MRNA, XETRA:0QF) shares fell almost 6% after the drugmaker announced that the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER) has issued a Refusal-to-File (RTF) letter for the company’s biologics license application for its...",
    "url": "https://finnhub.io/api/news?id=025925ab3363cc5b83f471ba95d9542b1961e7ff690637d6e0d9ac390c569320",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770832800,
      "headline": "Moderna's investigational flu vaccine denied FDA review, shares drop",
      "id": 139046756,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna Inc (NASDAQ:MRNA, XETRA:0QF) shares fell almost 6% after the drugmaker announced that the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER) has issued a Refusal-to-File (RTF) letter for the company’s biologics license application for its...",
      "url": "https://finnhub.io/api/news?id=025925ab3363cc5b83f471ba95d9542b1961e7ff690637d6e0d9ac390c569320"
    }
  },
  {
    "ts": null,
    "headline": "Exploring the top movers within the S&P500 index during today's session.",
    "summary": "Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Wednesday as we examine the latest happenings in today's session.",
    "url": "https://finnhub.io/api/news?id=5ebb883209fa5b2d187fe5d2771030144328fa3b83660d7244335b6176f7be99",
    "source": "ChartMill",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770831304,
      "headline": "Exploring the top movers within the S&P500 index during today's session.",
      "id": 139046253,
      "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
      "related": "MRNA",
      "source": "ChartMill",
      "summary": "Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Wednesday as we examine the latest happenings in today's session.",
      "url": "https://finnhub.io/api/news?id=5ebb883209fa5b2d187fe5d2771030144328fa3b83660d7244335b6176f7be99"
    }
  },
  {
    "ts": null,
    "headline": "Why Moderna Stock Is Sinking Today",
    "summary": "Moderna Stock Drops After FDA Rejects Flu Vaccine Filing",
    "url": "https://finnhub.io/api/news?id=dbd192828fdee3890d71c505476b0e27960efc36c80df4b35fa6ca45d4355f39",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770830974,
      "headline": "Why Moderna Stock Is Sinking Today",
      "id": 139046757,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna Stock Drops After FDA Rejects Flu Vaccine Filing",
      "url": "https://finnhub.io/api/news?id=dbd192828fdee3890d71c505476b0e27960efc36c80df4b35fa6ca45d4355f39"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Roundup: Market Talk",
    "summary": "0647 ET – Shares in Moderna fall 8% premarket after the U.S. Food and Drug Administration refused to review the drugmaker’s application to sell a new seasonal flu vaccine.  The FDA said Moderna failed to adequately compare the vaccine to its peers, though it didn’t cite safety or efficacy issues in a letter to the company.  The FDA’s decision could also impact the pending approval of Moderna’s combined Covid-19 and flu jab, in turn weighing on the company’s 2028 cash flow, the analysts say.",
    "url": "https://finnhub.io/api/news?id=1298d76508b38adb6fca2cc5c28a1a3aa47fa624d49ed41684900b48c7627af9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770830820,
      "headline": "Health Care Roundup: Market Talk",
      "id": 139046758,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "0647 ET – Shares in Moderna fall 8% premarket after the U.S. Food and Drug Administration refused to review the drugmaker’s application to sell a new seasonal flu vaccine.  The FDA said Moderna failed to adequately compare the vaccine to its peers, though it didn’t cite safety or efficacy issues in a letter to the company.  The FDA’s decision could also impact the pending approval of Moderna’s combined Covid-19 and flu jab, in turn weighing on the company’s 2028 cash flow, the analysts say.",
      "url": "https://finnhub.io/api/news?id=1298d76508b38adb6fca2cc5c28a1a3aa47fa624d49ed41684900b48c7627af9"
    }
  },
  {
    "ts": null,
    "headline": "FDA declines to review Moderna’s seasonal flu mRNA vaccine",
    "summary": "The FDA’s call comes within a wider push from the US government to alter vaccine policy.",
    "url": "https://finnhub.io/api/news?id=c9b8c11a9afd4966846202fd9d654dd89707bd6eb4547161be8b679e8903d753",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770828369,
      "headline": "FDA declines to review Moderna’s seasonal flu mRNA vaccine",
      "id": 139046759,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The FDA’s call comes within a wider push from the US government to alter vaccine policy.",
      "url": "https://finnhub.io/api/news?id=c9b8c11a9afd4966846202fd9d654dd89707bd6eb4547161be8b679e8903d753"
    }
  },
  {
    "ts": null,
    "headline": "MRNA Down Nearly 10% as FDA Refuses to Review Influenza Vaccine BLA",
    "summary": "Moderna shares sink 10% after FDA issues Refusal-to-File letter for its mRNA-1010 flu vaccine, citing trial design concerns despite no safety flags.",
    "url": "https://finnhub.io/api/news?id=f92275a1f28328ac3be4643ee4516f79d7bf9671ec2be693dadd3a9a38c08529",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770824700,
      "headline": "MRNA Down Nearly 10% as FDA Refuses to Review Influenza Vaccine BLA",
      "id": 139046760,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna shares sink 10% after FDA issues Refusal-to-File letter for its mRNA-1010 flu vaccine, citing trial design concerns despite no safety flags.",
      "url": "https://finnhub.io/api/news?id=f92275a1f28328ac3be4643ee4516f79d7bf9671ec2be693dadd3a9a38c08529"
    }
  },
  {
    "ts": null,
    "headline": "Senior FDA Official Says Secretary Robert F Kennedy Jr Has Not Been Involved In Vaccine Policy At The FDA",
    "summary": "-Reuters",
    "url": "https://finnhub.io/api/news?id=e5dc7c19753c1c14eaf614c67caae21e3cb06f7e427bd93574c6d0101686d0a9",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770824625,
      "headline": "Senior FDA Official Says Secretary Robert F Kennedy Jr Has Not Been Involved In Vaccine Policy At The FDA",
      "id": 139055803,
      "image": "",
      "related": "MRNA",
      "source": "Benzinga",
      "summary": "-Reuters",
      "url": "https://finnhub.io/api/news?id=e5dc7c19753c1c14eaf614c67caae21e3cb06f7e427bd93574c6d0101686d0a9"
    }
  },
  {
    "ts": null,
    "headline": "Gapping S&P500 stocks in Wednesday's session",
    "summary": "Stay updated with the S&P500 gap up and gap down stocks on Wednesday. Get a glimpse of the market's movement during today's session.",
    "url": "https://finnhub.io/api/news?id=a230e09d4a3dc8b90a26711ac1e6cf2f29c7a7275c6f609fb8a6009045ba8e46",
    "source": "ChartMill",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770824302,
      "headline": "Gapping S&P500 stocks in Wednesday's session",
      "id": 139044939,
      "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
      "related": "MRNA",
      "source": "ChartMill",
      "summary": "Stay updated with the S&P500 gap up and gap down stocks on Wednesday. Get a glimpse of the market's movement during today's session.",
      "url": "https://finnhub.io/api/news?id=a230e09d4a3dc8b90a26711ac1e6cf2f29c7a7275c6f609fb8a6009045ba8e46"
    }
  },
  {
    "ts": null,
    "headline": "FDA Says Moderna Exposed Participants, Age 65 And Over, To Increased Risk Of Severe Illness By Giving Them A Substandard Of Care Against The Recommendation Of FDA Career Scientists",
    "summary": "-Reuters Citing Statement",
    "url": "https://finnhub.io/api/news?id=ac1d991b6917319d38412e72cbb8118fdd9371f742dec47618be836c43339c76",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770822797,
      "headline": "FDA Says Moderna Exposed Participants, Age 65 And Over, To Increased Risk Of Severe Illness By Giving Them A Substandard Of Care Against The Recommendation Of FDA Career Scientists",
      "id": 139055804,
      "image": "",
      "related": "MRNA",
      "source": "Benzinga",
      "summary": "-Reuters Citing Statement",
      "url": "https://finnhub.io/api/news?id=ac1d991b6917319d38412e72cbb8118fdd9371f742dec47618be836c43339c76"
    }
  },
  {
    "ts": null,
    "headline": "Ancora to oppose WBD-Netflix deal, Kraft Heinz halts split plans",
    "summary": "Morning Brief Host Julie Hyman and Yahoo Finance Markets and Data Editor Jared Blikre track several of the day's top trending stock tickers, including the Wall Street Journal reporting that activist investor Ancora is positioned to oppose a potential deal between Warner Bros. Discovery (WBD) and Netfix (NFLX), Kraft Heinz (KHC) putting a pause on its plans to spin-off a segment of the food company, and the US Food and Drug Administration (FDA) refusing to review Moderna's (MRNA) new flu vaccine. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
    "url": "https://finnhub.io/api/news?id=b121fb99998437f0adce8eafb2368b9c0d16bd5c59a35af74942387c9b9a0eae",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770821094,
      "headline": "Ancora to oppose WBD-Netflix deal, Kraft Heinz halts split plans",
      "id": 139045097,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Morning Brief Host Julie Hyman and Yahoo Finance Markets and Data Editor Jared Blikre track several of the day's top trending stock tickers, including the Wall Street Journal reporting that activist investor Ancora is positioned to oppose a potential deal between Warner Bros. Discovery (WBD) and Netfix (NFLX), Kraft Heinz (KHC) putting a pause on its plans to spin-off a segment of the food company, and the US Food and Drug Administration (FDA) refusing to review Moderna's (MRNA) new flu vaccine. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
      "url": "https://finnhub.io/api/news?id=b121fb99998437f0adce8eafb2368b9c0d16bd5c59a35af74942387c9b9a0eae"
    }
  },
  {
    "ts": null,
    "headline": "Moderna: FDA RTF Derails mRNA-1010 And Reignites The Sell Case",
    "summary": "Moderna: FDA RTF Derails mRNA-1010 And Reignites The Sell Case",
    "url": "https://finnhub.io/api/news?id=48cb5754c2dda00fd71e39120b3e39b9f6d8a7efb0d2c45c8061f62754bf75d4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770818134,
      "headline": "Moderna: FDA RTF Derails mRNA-1010 And Reignites The Sell Case",
      "id": 139047393,
      "image": "",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=48cb5754c2dda00fd71e39120b3e39b9f6d8a7efb0d2c45c8061f62754bf75d4"
    }
  },
  {
    "ts": null,
    "headline": "These S&P500 stocks are moving in today's pre-market session",
    "summary": "Pre-market stock analysis of S&P500 stocks on 2026-02-11: top gainers and losers in today's session.",
    "url": "https://finnhub.io/api/news?id=f3b27d0392380f25e9abb33d1dd641abd9d9282ee303915beef0a25813df964b",
    "source": "ChartMill",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770816906,
      "headline": "These S&P500 stocks are moving in today's pre-market session",
      "id": 139041820,
      "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
      "related": "MRNA",
      "source": "ChartMill",
      "summary": "Pre-market stock analysis of S&P500 stocks on 2026-02-11: top gainers and losers in today's session.",
      "url": "https://finnhub.io/api/news?id=f3b27d0392380f25e9abb33d1dd641abd9d9282ee303915beef0a25813df964b"
    }
  },
  {
    "ts": null,
    "headline": "Blowout Jobs Report Drives Market To Magnet; Iran Risk Lingers; Bitcoin Whales Step In",
    "summary": "Blowout Jobs Report",
    "url": "https://finnhub.io/api/news?id=1f4be9e7198a828ccd00cd321b1534c7ffeb4621ac568c76bcc7e5225e40b9e5",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770816610,
      "headline": "Blowout Jobs Report Drives Market To Magnet; Iran Risk Lingers; Bitcoin Whales Step In",
      "id": 139055290,
      "image": "",
      "related": "MRNA",
      "source": "Benzinga",
      "summary": "\n\n\n\nBlowout Jobs Report\n\n\n",
      "url": "https://finnhub.io/api/news?id=1f4be9e7198a828ccd00cd321b1534c7ffeb4621ac568c76bcc7e5225e40b9e5"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Stock Sinks. The Puzzling Reason Its Flu Vaccine Was Rejected.",
    "summary": "The vaccine maker says the Food and Drug Administration has refused to review its application to sell a new seasonal flu vaccine.",
    "url": "https://finnhub.io/api/news?id=1b963560e55ad429c021a72a01c7a50cf45f090a6f3521d4c94219542253e4b0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770816240,
      "headline": "Moderna Stock Sinks. The Puzzling Reason Its Flu Vaccine Was Rejected.",
      "id": 139042747,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The vaccine maker says the Food and Drug Administration has refused to review its application to sell a new seasonal flu vaccine.",
      "url": "https://finnhub.io/api/news?id=1b963560e55ad429c021a72a01c7a50cf45f090a6f3521d4c94219542253e4b0"
    }
  },
  {
    "ts": null,
    "headline": "Earnings live: Vertiv stock soars on upbeat outlook, Lyft and Robinhood shares tumble, Mattel plunges",
    "summary": "The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far.",
    "url": "https://finnhub.io/api/news?id=c603190fba3c8783492e2ee0d2fc462d00ac124bd161f4275ad16db76c26c1bc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770815519,
      "headline": "Earnings live: Vertiv stock soars on upbeat outlook, Lyft and Robinhood shares tumble, Mattel plunges",
      "id": 139042275,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far.",
      "url": "https://finnhub.io/api/news?id=c603190fba3c8783492e2ee0d2fc462d00ac124bd161f4275ad16db76c26c1bc"
    }
  },
  {
    "ts": null,
    "headline": "Stocks making the biggest moves midday: Acadia Healthcare, Vertiv, Moderna, Unity Software, Generac & more",
    "summary": "These are the stocks posting the largest moves in midday trading.",
    "url": "https://finnhub.io/api/news?id=1f475bf4e0bf74fb1b6a473bc5d262c36d598b66b3f0a070434bd15f4b53fdb5",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770813545,
      "headline": "Stocks making the biggest moves midday: Acadia Healthcare, Vertiv, Moderna, Unity Software, Generac & more ",
      "id": 139046199,
      "image": "https://image.cnbcfm.com/api/v1/image/108063804-1731687828868-Vertiv-Photo-OB-MW-20241115-PRESS-6.jpg?v=1731687955&w=1920&h=1080",
      "related": "MRNA",
      "source": "CNBC",
      "summary": "These are the stocks posting the largest moves in midday trading. ",
      "url": "https://finnhub.io/api/news?id=1f475bf4e0bf74fb1b6a473bc5d262c36d598b66b3f0a070434bd15f4b53fdb5"
    }
  },
  {
    "ts": null,
    "headline": "Moderna shares are trading lower after the company announced it received a refusal-to-file letter from the FDA for mRNA-1010.",
    "summary": "Moderna shares are trading lower after the company announced it received a refusal-to-file letter from the FDA for mRNA-1010.",
    "url": "https://finnhub.io/api/news?id=33fa96e303056296ff89196001f1b6a342476ff2fd34b5f2c63708d34bb59d2f",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770811231,
      "headline": "Moderna shares are trading lower after the company announced it received a refusal-to-file letter from the FDA for mRNA-1010.",
      "id": 139055806,
      "image": "",
      "related": "MRNA",
      "source": "Benzinga",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=33fa96e303056296ff89196001f1b6a342476ff2fd34b5f2c63708d34bb59d2f"
    }
  },
  {
    "ts": null,
    "headline": "Moderna shares fall as FDA declines to review new flu vaccine",
    "summary": "Feb 11 (Reuters) - Shares of Moderna slumped nearly 9% in premarket trading on Wednesday after the U. Food and Drug Administration declined ‌to review the company's application for approval of its experimental influenza ‌vaccine, underscoring shifts in U.",
    "url": "https://finnhub.io/api/news?id=fccc37e7356cd0dbf56e82e686d126563611c2f6f993476ce515f3902da845a3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770810291,
      "headline": "Moderna shares fall as FDA declines to review new flu vaccine",
      "id": 139041197,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Feb 11 (Reuters) - Shares of Moderna slumped nearly 9% in premarket trading on Wednesday after the U. Food and Drug Administration declined ‌to review the company's application for approval of its experimental influenza ‌vaccine, underscoring shifts in U.",
      "url": "https://finnhub.io/api/news?id=fccc37e7356cd0dbf56e82e686d126563611c2f6f993476ce515f3902da845a3"
    }
  },
  {
    "ts": null,
    "headline": "'The unusual Prasad missive in the FDA's rejection of the Moderna flu shot application'- STAT News",
    "summary": "https://www.statnews.com/2026/02/11/biotech-news-prasad-missive-fda-moderna-flu-shot-rejection/?utm_source=twitter&amp;utm_campaign=twitter_organic&amp;utm_medium=social",
    "url": "https://finnhub.io/api/news?id=2aef183bdff40bd0078ec8e997890b801fe154cad0fefeb9e28a97c4b2ead8b5",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770809947,
      "headline": "'The unusual Prasad missive in the FDA's rejection of the Moderna flu shot application'- STAT News",
      "id": 139055807,
      "image": "",
      "related": "MRNA",
      "source": "Benzinga",
      "summary": "https://www.statnews.com/2026/02/11/biotech-news-prasad-missive-fda-moderna-flu-shot-rejection/?utm_source=twitter&amp;utm_campaign=twitter_organic&amp;utm_medium=social",
      "url": "https://finnhub.io/api/news?id=2aef183bdff40bd0078ec8e997890b801fe154cad0fefeb9e28a97c4b2ead8b5"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Are Today’s Movers: Moderna, Robinhood, Cloudflare, Humana, Lyft, Mattel, Beta Technologies, Gilead, and More",
    "summary": "Shares in Moderna tumble after the company says the Food and Drug Administration refuses to review a seasonal flu vaccine application.",
    "url": "https://finnhub.io/api/news?id=79a57ca5050052fa9ffb252d3547b02d36393490128be34ebf19696fc1b83e57",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770809340,
      "headline": "These Stocks Are Today’s Movers: Moderna, Robinhood, Cloudflare, Humana, Lyft, Mattel, Beta Technologies, Gilead, and More",
      "id": 139041061,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Shares in Moderna tumble after the company says the Food and Drug Administration refuses to review a seasonal flu vaccine application.",
      "url": "https://finnhub.io/api/news?id=79a57ca5050052fa9ffb252d3547b02d36393490128be34ebf19696fc1b83e57"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to Watch Wednesday: Warner/Netflix, Moderna, SLB",
    "summary": "? Warner Bros. Discovery (WBD): Activist investor Ancora has built a roughly $200 million stake in Warner and plans to oppose its deal with Netflix (NFLX). Ancora thinks Warner failed to adequately engage with Paramount Skydance (PSKY)'s rival offer.",
    "url": "https://finnhub.io/api/news?id=cd6aef0ffeacd47bdc5008169fed829a6fb9e3f637486a9af39d294bf59c0e32",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770806454,
      "headline": "Stocks to Watch Wednesday: Warner/Netflix, Moderna, SLB",
      "id": 139041120,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "? Warner Bros. Discovery (WBD): Activist investor Ancora has built a roughly $200 million stake in Warner and plans to oppose its deal with Netflix (NFLX). Ancora thinks Warner failed to adequately engage with Paramount Skydance (PSKY)'s rival offer.",
      "url": "https://finnhub.io/api/news?id=cd6aef0ffeacd47bdc5008169fed829a6fb9e3f637486a9af39d294bf59c0e32"
    }
  },
  {
    "ts": null,
    "headline": "Evommune rockets on eczema data; AstraZeneca advances GLP-1 pill",
    "summary": "Shares of Evommune nearly doubled on data suggesting it has a potential threat to Dupixent. Elsewhere, a closely watched narcolepsy drug got an FDA decision date and investors scrutinized Upstream’s asthma results.",
    "url": "https://finnhub.io/api/news?id=603b3095d0177beb97ccb77e34785ab3c5e7f04f443ea51515d942ad6e559ce7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770802380,
      "headline": "Evommune rockets on eczema data; AstraZeneca advances GLP-1 pill",
      "id": 139045215,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Shares of Evommune nearly doubled on data suggesting it has a potential threat to Dupixent. Elsewhere, a closely watched narcolepsy drug got an FDA decision date and investors scrutinized Upstream’s asthma results.",
      "url": "https://finnhub.io/api/news?id=603b3095d0177beb97ccb77e34785ab3c5e7f04f443ea51515d942ad6e559ce7"
    }
  },
  {
    "ts": null,
    "headline": "Mattel Posts Downbeat Earnings, Joins Lyft, Robinhood And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session",
    "summary": "",
    "url": "https://finnhub.io/api/news?id=e0a8d1ccf6bbc643b8c555dd312a85b9084aa5c53af895eeeb1bc138348a0b84",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770800527,
      "headline": "Mattel Posts Downbeat Earnings, Joins Lyft, Robinhood And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session",
      "id": 139041815,
      "image": "https://cdn.benzinga.com/files/images/story/2026/02/11/El-Segundo--California--Usa---July-5--20_1.jpeg?width=2048&height=1536",
      "related": "MRNA",
      "source": "Benzinga",
      "summary": " ",
      "url": "https://finnhub.io/api/news?id=e0a8d1ccf6bbc643b8c555dd312a85b9084aa5c53af895eeeb1bc138348a0b84"
    }
  },
  {
    "ts": null,
    "headline": "Cisco Earnings, Jobs Report, CPI Data: Still to Come This Week",
    "summary": "This week brings a deluge of economic indicators, particularly jobs and inflation reports, which were stalled by the recent government closure. Another shutdown may loom if Congress doesn't reach a deal on immigration enforcement.",
    "url": "https://finnhub.io/api/news?id=f4ba92f78402c3e6ecf129850ac27443510993c3aa78149523fb82f3b7b64074",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770799130,
      "headline": "Cisco Earnings, Jobs Report, CPI Data: Still to Come This Week",
      "id": 139040464,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "This week brings a deluge of economic indicators, particularly jobs and inflation reports, which were stalled by the recent government closure. Another shutdown may loom if Congress doesn't reach a deal on immigration enforcement.",
      "url": "https://finnhub.io/api/news?id=f4ba92f78402c3e6ecf129850ac27443510993c3aa78149523fb82f3b7b64074"
    }
  },
  {
    "ts": null,
    "headline": "12 Health Care Stocks Moving In Wednesday's Pre-Market Session",
    "summary": "",
    "url": "https://finnhub.io/api/news?id=3307b742c439de0d9c643b0bd6d26fa541eeae3526663b380208d008c16a8a83",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770797149,
      "headline": "12 Health Care Stocks Moving In Wednesday's Pre-Market Session",
      "id": 139041779,
      "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=2048&height=1536",
      "related": "MRNA",
      "source": "Benzinga",
      "summary": " ",
      "url": "https://finnhub.io/api/news?id=3307b742c439de0d9c643b0bd6d26fa541eeae3526663b380208d008c16a8a83"
    }
  },
  {
    "ts": null,
    "headline": "January's jobs report, Ford earnings, Epstein fallout and more in Morning Squawk",
    "summary": "Here are five key things investors need to know to start the trading day.",
    "url": "https://finnhub.io/api/news?id=a8161c5fceb1b4cfbaf10d34ebccac6e5b8d77159f666f84e79df336545108cb",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770796728,
      "headline": "January's jobs report, Ford earnings, Epstein fallout and more in Morning Squawk",
      "id": 139045942,
      "image": "https://image.cnbcfm.com/api/v1/image/108264104-1770755295109-gettyimages-2258362644-4045_48_2026_4373.jpeg?v=1770818043&w=1920&h=1080",
      "related": "MRNA",
      "source": "CNBC",
      "summary": "Here are five key things investors need to know to start the trading day.",
      "url": "https://finnhub.io/api/news?id=a8161c5fceb1b4cfbaf10d34ebccac6e5b8d77159f666f84e79df336545108cb"
    }
  },
  {
    "ts": null,
    "headline": "Stocks making the biggest moves premarket: Lyft, Moderna, Cloudflare, Ford, Zillow Group and more",
    "summary": "These are the stocks posting the largest moves in early trading.",
    "url": "https://finnhub.io/api/news?id=94a7e9f623564b004fe7dc7946ed92a4fc99cef4b9b664a4703180d93139fd2a",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770795319,
      "headline": "Stocks making the biggest moves premarket: Lyft, Moderna, Cloudflare, Ford, Zillow Group and more",
      "id": 139046183,
      "image": "https://image.cnbcfm.com/api/v1/image/108264090-1770753983636-gettyimages-2260939487-_73a9977_trkhhr2n.jpeg?v=1770754142&w=1920&h=1080",
      "related": "MRNA",
      "source": "CNBC",
      "summary": "These are the stocks posting the largest moves in early trading. ",
      "url": "https://finnhub.io/api/news?id=94a7e9f623564b004fe7dc7946ed92a4fc99cef4b9b664a4703180d93139fd2a"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Received Refusal-To-File Letter From FDA For mRNA-1010",
    "summary": "Moderna Received Refusal-To-File Letter From FDA For mRNA-1010",
    "url": "https://finnhub.io/api/news?id=ee1e06623ba2798c8eb891eaf93dff68b1692a18877082591040a2f609b0d9bc",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770793484,
      "headline": "Moderna Received Refusal-To-File Letter From FDA For mRNA-1010",
      "id": 139043495,
      "image": "",
      "related": "MRNA",
      "source": "Benzinga",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=ee1e06623ba2798c8eb891eaf93dff68b1692a18877082591040a2f609b0d9bc"
    }
  },
  {
    "ts": null,
    "headline": "FDA refuses to review Moderna’s mRNA flu vaccine",
    "summary": "Moderna claimed that the decision, issued by top vaccine regulator Vinay Prasad, was “inconsistent” with prior FDA communications and went against the regulator’s established guidance for flu shots.",
    "url": "https://finnhub.io/api/news?id=cc6db9c80d9a74761ca7cc6a85abdd567ad841f9d6e7f6f5492ddaac78a1fa74",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770792540,
      "headline": "FDA refuses to review Moderna’s mRNA flu vaccine",
      "id": 139042749,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna claimed that the decision, issued by top vaccine regulator Vinay Prasad, was “inconsistent” with prior FDA communications and went against the regulator’s established guidance for flu shots.",
      "url": "https://finnhub.io/api/news?id=cc6db9c80d9a74761ca7cc6a85abdd567ad841f9d6e7f6f5492ddaac78a1fa74"
    }
  },
  {
    "ts": null,
    "headline": "Moderna: FDA refused to consider approving use of company's new mRNA flu vaccine",
    "summary": "CNBC's Kelly Evans reports on the latest news.",
    "url": "https://finnhub.io/api/news?id=56b6f5d082fab113d14c05a8058e884d84b36a5872fcdf1caa62de9a2dd5f6e7",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770792342,
      "headline": "Moderna: FDA refused to consider approving use of company's new mRNA flu vaccine",
      "id": 139046202,
      "image": "https://image.cnbcfm.com/api/v1/image/108264320-17708100371770810034-43968088276-1080pnbcnews.jpg?v=1770810036&w=1920&h=1080",
      "related": "MRNA",
      "source": "CNBC",
      "summary": "CNBC's Kelly Evans reports on the latest news.",
      "url": "https://finnhub.io/api/news?id=56b6f5d082fab113d14c05a8058e884d84b36a5872fcdf1caa62de9a2dd5f6e7"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Breakfast Podcast: Amazon Adds BETA To Cart",
    "summary": "Amazon takes 5.3% stake in BETA Technologies, shares higher. Moderna drops after FDA refuses to file for mRNA-1010 influenza vaccine. EstÃ©e Lauder sues Walmart for selling counterfeits.",
    "url": "https://finnhub.io/api/news?id=01797fe92b9b4942063b346809e3bc2e0a418ddb3ffe4abaebb0580c3353aacc",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770791066,
      "headline": "Wall Street Breakfast Podcast: Amazon Adds BETA To Cart",
      "id": 139040882,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1317474419/image_1317474419.jpg?io=getty-c-w1536",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "Amazon takes 5.3% stake in BETA Technologies, shares higher. Moderna drops after FDA refuses to file for mRNA-1010 influenza vaccine. EstÃ©e Lauder sues Walmart for selling counterfeits.",
      "url": "https://finnhub.io/api/news?id=01797fe92b9b4942063b346809e3bc2e0a418ddb3ffe4abaebb0580c3353aacc"
    }
  },
  {
    "ts": null,
    "headline": "FDA Refuses To Review Moderna's Influenza Shot Application",
    "summary": "Moderna stock fell as FDA refused to review its influenza vaccine due to choice of comparator; CEO requests meeting for clarification.",
    "url": "https://finnhub.io/api/news?id=81e59ba3d09bcf0cbdab2d03159be326bb0a14b7ad971c5fe11fa95673c55fda",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770790912,
      "headline": "FDA Refuses To Review Moderna's Influenza Shot Application",
      "id": 139043496,
      "image": "https://cdn.benzinga.com/files/images/story/2026/02/11/Moderna-Inc-.jpeg?width=2048&height=1536",
      "related": "MRNA",
      "source": "Benzinga",
      "summary": "Moderna stock fell as FDA refused to review its influenza vaccine due to choice of comparator; CEO requests meeting for clarification.",
      "url": "https://finnhub.io/api/news?id=81e59ba3d09bcf0cbdab2d03159be326bb0a14b7ad971c5fe11fa95673c55fda"
    }
  },
  {
    "ts": null,
    "headline": "Why Teradata Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket",
    "summary": "",
    "url": "https://finnhub.io/api/news?id=d910585fddff04daed191a93f47e6c9a4b46f8b6194b8d808fd4e7f0ec53f56b",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770787539,
      "headline": "Why Teradata Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket",
      "id": 139041898,
      "image": "https://cdn.benzinga.com/files/images/story/2026/02/11/Section-Of-A-Financial-Newspaper-Titled-.jpeg?width=2048&height=1536",
      "related": "MRNA",
      "source": "Benzinga",
      "summary": " ",
      "url": "https://finnhub.io/api/news?id=d910585fddff04daed191a93f47e6c9a4b46f8b6194b8d808fd4e7f0ec53f56b"
    }
  },
  {
    "ts": null,
    "headline": "FDA Refuses to Consider Approving Use of Moderna’s New Flu Vaccine",
    "summary": "The company said the agency wouldn’t review its application on the grounds that the study testing the shot wasn’t sufficient.",
    "url": "https://finnhub.io/api/news?id=2abdd750e4ada3cfafbcc40f3301a3ead135fd2b5c052ddf4cfff2039ce4d87d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770768840,
      "headline": "FDA Refuses to Consider Approving Use of Moderna’s New Flu Vaccine",
      "id": 139038420,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The company said the agency wouldn’t review its application on the grounds that the study testing the shot wasn’t sufficient.",
      "url": "https://finnhub.io/api/news?id=2abdd750e4ada3cfafbcc40f3301a3ead135fd2b5c052ddf4cfff2039ce4d87d"
    }
  }
]